Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Search for non-coding mutations in patients with cblC and mut inborn errors of cobalamin metabolism
FY 2012-13
Summary
Inborn errors of vitamin B12 metabolism are rare, recessive genetic disorders. Affected patients cannot properly metabolize vitamin B12, often leading to neurological problems, anemia, developmental delay or death. There are currently nine known classes, each caused by mutations in a specific gene. Being recessive diseases, patients must have a genetic mutation in both the maternal and paternal copies. Patients are classified by functional cell assays performed in our laboratory and the mutations are found by sequencing the patient's DNA in the gene's protein coding region. However, one or both mutations may lie outside this region. Identification of these non-coding mutations is much less common but are likely more prevalent than previously thought due to the relative difficulty in finding them. The goal of this project is to find and characterize non-coding mutations in two of the nine classes: cblC and mut. In our current patient inventory, twenty cblC and eight mut patients are ideal candidates as one or both mutations remain unidentified after DNA sequencing.
An important benefit of this research is that it will provide more knowledge in non-coding mutations' role in causing rare genetic disease. Since they are more complicated to find, their importance has likely been under-represented in research to date. Characterizing these mutations would improve health care delivery for the affected families. For most cases of inborn errors of vitamin B12 metabolism, there are no good therapies available. Since a couple with an affected child has a one in four chance of then having another sick child, family planning is the only option to avoid these diseases' severe effects. Identifying the mutations that cause a child's disease is essential for pre-implantation diagnosis, the process where early embryos are screened for genetic mutations before being implanted in the mother. It also makes prenatal diagnosis, or screening the fetus for these diseases, much easier.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
281287
Name
Brebner Alison
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Search for non-coding mutations in patients with cblC and mut inborn errors of cobalamin metabolism
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Human Genetics; Metabolic Disease; Mutation Analysis; Non-Coding Mutations; Patient-Focused Research; Pcr; Sequencing; Vitamin B12
Abstract
Inborn errors of vitamin B12 metabolism are rare, recessive genetic disorders. Affected patients cannot properly metabolize vitamin B12, often leading to neurological problems, anemia, developmental delay or death. There are currently nine known classes, each caused by mutations in a specific gene. Being recessive diseases, patients must have a genetic mutation in both the maternal and paternal copies. Patients are classified by functional cell assays performed in our laboratory and the mutations are found by sequencing the patient's DNA in the gene's protein coding region. However, one or both mutations may lie outside this region. Identification of these non-coding mutations is much less common but are likely more prevalent than previously thought due to the relative difficulty in finding them. The goal of this project is to find and characterize non-coding mutations in two of the nine classes: cblC and mut. In our current patient inventory, twenty cblC and eight mut patients are ideal candidates as one or both mutations remain unidentified after DNA sequencing.
An important benefit of this research is that it will provide more knowledge in non-coding mutations' role in causing rare genetic disease. Since they are more complicated to find, their importance has likely been under-represented in research to date. Characterizing these mutations would improve health care delivery for the affected families. For most cases of inborn errors of vitamin B12 metabolism, there are no good therapies available. Since a couple with an affected child has a one in four chance of then having another sick child, family planning is the only option to avoid these diseases' severe effects. Identifying the mutations that cause a child's disease is essential for pre-implantation diagnosis, the process where early embryos are screened for genetic mutations before being implanted in the mother. It also makes prenatal diagnosis, or screening the fetus for these diseases, much easier.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brebner, Alison
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~